Pion Inc Unveils New Model of its Industry-First Subcutaneous Injection Site Simulator Investigate Drug Release Performance of Subcutaneous Formulations In Vitro, With New SCISSOR N3
MA. November 16: Pion Inc, leading provider of analytical instruments that bridge the gap between in vitro experiments and in vivo outcomes launches the SCISSOR N3, its new Subcutaneous Injection Site Simulator.